Answer
Upstaza (eladocagene exuparvovec) is contraindicated in patients with hypersensitivity to the active substance or any excipient listed in section 6.1.
Sources for this answer
- Upstaza (Eladocagene exuparvovec) solution for infusionPTC Therapeutics Ltd · emc · SmPC §4.3 Contraindications · Version 8Document updated
Sources checked